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Abstract
Experimental Data
Orexinergic neurotransmission is involved in mediating temperature responses to metham-
phetamine (Meth). In experiments in rats, SB-334867 (SB), an antagonist of orexin recep-
tors (OX1R), at a dose of 10 mg/kg decreases late temperature responses (t>60 min) to an
intermediate dose of Meth (5 mg/kg). A higher dose of SB (30 mg/kg) attenuates tempera-
ture responses to low dose (1 mg/kg) of Meth and to stress. In contrast, it significantly exag-
gerates early responses (t<60 min) to intermediate and high doses (5 and 10 mg/kg) of
Meth. As pretreatment with SB also inhibits temperature response to the stress of injection,
traditional statistical analysis of temperature responses is difficult.
Mathematical Modeling
We have developed a mathematical model that explains the complexity of temperature re-
sponses to Meth as the interplay between excitatory and inhibitory nodes. We have extended
the developed model to include the stress of manipulations and the effects of SB. Stress is
synergistic with Meth on the action on excitatory node. Orexin receptors mediate an activation
of on both excitatory and inhibitory nodes by low doses of Meth, but not on the node activated
by high doses (HD). Exaggeration of early responses to high doses of Meth involves disinhibi-
tion: low dose of SB decreases tonic inhibition ofHD and lowers the activation threshold,
while the higher dose suppresses the inhibitory component. Using a modeling approach to
data assimilation appears efficient in separating individual components of complex response
with statistical analysis unachievable by traditional data processing methods.
PLOS ONE | DOI:10.1371/journal.pone.0126719 May 20, 2015 1 / 20
OPEN ACCESS
Citation: Behrouzvaziri A, Fu D, Tan P, Yoo Y,
Zaretskaia MV, Rusyniak DE, et al. (2015)
Orexinergic Neurotransmission in Temperature
Responses to Methamphetamine and Stress:
Mathematical Modeling as a Data Assimilation
Approach. PLoS ONE 10(5): e0126719. doi:10.1371/
journal.pone.0126719
Academic Editor: Vladimir E. Bondarenko, Georgia
State University, UNITED STATES
Received: January 7, 2015
Accepted: April 7, 2015
Published: May 20, 2015
Copyright: © 2015 Behrouzvaziri et al. This is an
open access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: Research reported in this publication was
supported by the National Institute on Drug Abuse of
the NIH under award number R01DA026867 to DER,
and iM2CS-GEIRE and RSFG grants to YIM and
DVZ. Furthermore, this work was conducted in a
facility constructed under support from the National
Center for Research Resources, of the NIH under
award number C06 RR015481-010. The funders had
Introduction
Amphetamine and its derivatives are among the most prevalent abused drugs in the world [1].
Amphetamines can cause various medical complications including myocardial infarctions, is-
chemic and hemorrhagic strokes, rhabdomyolysis, renal failure, and fatal hyperthermia [2–8].
Despite this, there is little understanding of neural mechanisms underlying hyperthermia pro-
duced by amphetamines. For instance a similar dose of amphetamine may cause a mild effect
in some patients but be fatal to others; this can occur even though the blood levels of the drug
appear low [9, 10].
In rats, amphetamines cause the central release of monoamines and the subsequent activa-
tion of the sympathetic nervous system causing in heat generation by brown adipose tissue
(BAT) [11, 12] and skeletal muscle [13]. In addition, amphetamines decrease heat dissipation
through cutaneous vasoconstriction [14, 15]. The brain areas mediating these effects are not
known but we have previously shown that sympathetic and behavioral responses mediated, by
the substituted amphetamine MDMA, can be prevented by suppressing neuronal activity in
the dorsomedial hypothalamus [16], the area which is now well-established to participate in
the control of heat production in the BAT and heat dissipation through the skin [17]. This is
one of the few brain regions containing neurons that project trans-synaptically to both the ad-
renal gland and skeletal muscle [18] and these dual-projecting neurons contain the peptide
orexin [19]. It has also been further shown that Meth and d-amphetamine activate orexin-con-
taining neurons [20, 21].
Central activation of orexin receptors increases body temperature, BAT sympathetic nerve
activity and thermogenesis, plasma epinephrine, and heart rate [22–26]. The systemic adminis-
tration of SB-334867 (SB), an OX1R antagonist, hereinafter referred as SB, prevents increases
in heart rate and mean arterial pressure in models of stress and panic [27, 28], and suppresses
hyperthermia caused by stress of injection [29]. Pretreatment with SB has also been shown to
significantly attenuate hyperthermia evoked by a moderate but not a low or high dose of Meth
[29]. Unfortunately, in the cited study temperature fluctuations resulting from the stress of two
intraperitoneal injections (SB and Meth) made it impossible to quantify the effect of SB on low
doses of Meth using a traditional data analysis.
The differential effects of SB on the temperature responses to different doses of Meth do not
allow for a straight-forward interpretation. Recently, we developed a mathematical model [30]
that reproduced dose-dependent temperature responses to methamphetamine. The model de-
scribed interactions of putative brain nuclei that participate in thermoregulation. We use this
model to provide mechanistic explanation of how the orexin antagonist SB-334867 affects
complex Meth-induced dynamics of the body temperature.
Materials and Methods
Animal experiments
Animals. Male Sprague-Dawley rats (280–350 g) were individually housed with a 12 h
light cycle at a room temperature of 23–25°C with free access to food and water. All animals
for which data are reported remained in good health throughout the course of surgical proce-
dures and experimental protocols as assessed by appearance, behavior, and maintenance of
body weight. All procedures described here were approved by the Indiana University School of
Medicine Institutional Animal Care and Use Committee and followed NIH guidelines.
Surgical Procedures. For measurements of core temperature, rats were implanted with
telemetric transmitters (C50-PXT, Data Sciences Int., St.Paul, MN) under isoflurane anesthesia
as previously described [31]. The body of the transmitter was placed into the abdominal cavity
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and sutured to the abdominal wall. After at least seven days of recovery, rats, still in their home
cages, were brought to experimental room. Cages were placed on telemetric receivers (RPC-1),
and animals were given at least two hours to adapt to the new environment.
Drugs. The orexin-1 receptor antagonist SB-334867 (Tocris Bioscience, Ellisville, MO)
was dissolved immediately before injection, and administered in the volume of 1 ml/kg. For in-
jections of 10 mg/kg, 10 mg of SB was dissolved in 40 μl DMSO, followed by addition of 60 μl
of 1 M HCl, and 900 μl of 10% 2-hydroxypropyl-β-cyclodextrin (Sigma-Aldrich, St. Louis,
MO) in saline. For injections of 30 mg/kg, 50 mg of SB was dissolved in 300 μl DMSO, followed
by addition of 160 μl of 1 M HCl, and 1200 μl of 10% 2-hydroxypropyl-β-cyclodextrin in saline.
These procedures provided clear yellow solutions without evidence of flocculation. The vehi-
cles were prepared in the same way without the drug.
Methamphetamine hydrochloride (Sigma-Aldrich, St. Louis, MO) was dissolved in sterile
saline at the time of injections and injected at a volume of 1 ml/kg.
Experimental protocol: The effect of SB-334867 on methamphetamine-evoked re-
sponses. Two separate experimental series were performed. In the first series SB was adminis-
tered in the dose of 10 mg/kg. In second series, SB was administered in the dose 30 mg/kg. In
each study we have used the corresponding vehicles (see above).
In each series rats were randomly assigned to one of eight groups (n = 6–8 per group): one
of two pretreatments (SB vs vehicle), followed by one of four treatments (saline or one of three
doses of Meth). Each rat received only one treatment. Experiments were performed in a tem-
perature controlled room at T = 25°C and relative humidity 30–70%. Air temperature and hu-
midity were monitored by independent sensors. For all experiments deviations of the
temperature from 25°C did not exceed 0.8°C. After baseline physiological parameters were re-
corded for at least 30 min, animals received an intraperitoneal injection of either vehicle or SB-
334867. Thirty min later, rats received an intraperitoneal injection of either saline or one of
three doses of methamphetamine (1 mg/kg, 5 mg/kg, or 10 mg/kg). Although there is a wide
range of methamphetamine doses that humans abuse, the doses we chose include ones that are
commonly used recreationally (1 mg/kg) as well as larger doses that may be reached by binge
users (5 and 10 mg/kg) [32]. For convenience we refer to these doses as “low”, “moderate”, and
“high” respectively. Each rat was used for only one injection of Meth or saline.
Statistical analysis. The results are presented as the mean ± SEM. Results were compared
using a one way ANOVA with repeated measures followed by a Fisher’s LSD post hoc test,
where appropriate. A value of P<0.05 was considered to indicate a significant difference in all
comparisons. Baseline levels of locomotor activity, temperature, HR and MBP did not differ
between groups across the series of experiments, so changes from baseline were analyzed.
Mathematical Modeling
General approach. In our initial studies [30] we were able to fit experimental data on
dose-dependence of temperature responses to Meth with appropriate precision using a mathe-
matical model which was constructed using known anatomy of circuitry involved into re-
sponses to amphetamines. The core of the model is a feed-forward sequence of connected
excitatory nodes: Excitatory (Exc, putatively hypothalamic), Medullary (Med) and sympathetic
premotor node (SPN), out of which SPN directly defines a heat generation output (Fig 1). We
assume that the signal from SPN is transmitted “as is” to the effector organs controlling ther-
mogenesis. This allows combining the whole downstream chain into a single output. Excitatory
node is sensitive to Meth as well as there are two more Meth-sensitive nodes—Inhibitory
(Inhib) and “high dose” (HD). The Inhibitory drive competes with the Excitatory input to affect
the Medullary node, while theHD node requires high dose of Meth to be activated, hence the
Orexin and Temperature Response to Meth and Stress
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name. Complex dose-dependence of temperature responses to Meth is formed by the competi-
tion of two excitatory inputs and one inhibitory input, all of which have different sensitivities
to Meth.
Low doses of Meth (1 mg/kg i.p. and below) activate the Excitatory node almost exclusively,
and administration of those doses evokes a monophasic mild hyperthermia. Higher doses (3–5
mg/kg i.p.) are able to activate the inhibitory node, which completely masks the activity of the
Excitatory node. As a result, immediately after injection of Meth there is no temperature re-
sponse, but after partial elimination of the drug, the excitatory drive is disinhibited, and tem-
perature increases display a delayed monophasic response. Finally, high doses (10 mg/kg i.p.)
activate theHD node, and cause immediate powerful hyperthermia followed by a secondary
temperature increase due to transient activation of the Excitatory node.
To analyze the orexin data we first modified the existing model to accommodate stress.
Since inhibition of the dorsomedial hypothalamus, a putative excitatory node, suppresses sym-
pathetic activation from both stress [33] and amphetamines [16], we hypothesized that stress
and Meth both provide direct inputs to the Excitatory node. Each stress stimulus was modeled
as a spike of activity of short duration.
Next, we assumed that SB affects Meth and stress inputs at the relevant nodes. Excitatory
node exhibits some tonic activity without Meth [30]. If the projections from Excitatory and/or
Inhibitory node to Medullary node are orexinergic, the antagonist would cause dramatic (up to
3°C) hypothermia by itself. However, as it will be shown in the Results, the administration of
the antagonist alone did not result in any hypothermia whatsoever. Therefore, we were restrict-
ed to placing orexin receptors on the Meth-sensitive populations to mediate effects of Meth,
but not to cause any perturbations by the receptor blockade alone.
Fig 1. Schematic of the model neuronal circuitry involved in responses to methamphetamine. Stress input and the orexin receptors (shown by gray
rectangles labeled “OX”) are added to extend the circuitry used in [30]. Effect of Stress and/or Meth can be affected by the orexin receptor antagonist SB-
334867. Each circle represents a neural population. Abbreviations: Exc—excitatory node, Inhib—inhibitory node,HD—high-dose activated node,Med—
medullary node, SPN—sympathetic preganglionic node, TEMP—temperature. See text for a detailed description.
doi:10.1371/journal.pone.0126719.g001
Orexin and Temperature Response to Meth and Stress
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By fitting the temperature responses to Meth after different doses of SB we calculated values
of the model parameters.
Implementation of the model. The model consisted of three components: pharmacoki-
netics describing concentration of Meth in the blood after injection; a neural network whose
activity was dependent on Meth and SB; and a temperature control system driven by a signal
from the neural network.
We assumed that after the injection the drug is being absorbed in the blood from the perito-
neum and is also being eliminated from the blood. Accordingly, drug concentrations are de-
scribed by the following equations:
d½Mp
dt
¼  ½Mp
tu
ð1Þ
d½M
dt
¼ ½Mp
tu
 ½M
td
where t is time in minutes,Mp is the intra-peritoneal drug concentration, andM is the blood
drug concentration (both in mg/kg). [Mp]/τu represents drug absorption with time constant τu,
and [M]/τd represents drug elimination with time constant τd. Initial conditions are [Mp](0) =
D, [M](0) = 0 for injections made at time 0 where D is the initial dose of the drug being mod-
eled. System (1) can be solved explicitly as:
½MðtÞ ¼ D tu
td
 1
 1
ðet=tu  et=tdÞ ð2Þ
for t> 0, and [M](t) = 0 if t< 0. Stress input from the injection made at t = t0 was modeled as
a single exponential function
Sðt; t0Þ ¼
(
eðtt0Þ=ts ; if t > t0
0; if t  t0
ð3Þ
In our study, the neural circuitry is modeled as a feed-forward artificial neural network. The
excitatory node Exc receives two stress inputs at t = −30 min and t = 0 min from injections of
SB (or vehicle) and Meth (or saline) respectively. The outputs of Meth-sensitive neural popula-
tions are calculated as follows:
PExcðtÞ ¼ sðwSSðt;  30Þ þ wSSðt; 0Þ þ wExc½MðtÞ þ gExcÞ
PInhðtÞ ¼ sðwInh½MðtÞ þ gInhÞ
PHDðtÞ ¼ sðwHD½MðtÞ þ gHDÞ
ð4Þ
where σ(x) = (1 + tanhx)/2 is a sigmoid activation function, wi(t) is the sensitivity of Pi(t) to
Meth, and γi is the basal excitability of Pi, i ∊ {Exc, Inh,HD}. To account for the effect of the SB,
we used different values of (wS, wExc, wInh, wHD) for different doses of SB.
The activity of medullary populationMed is described as follows:
PMedðtÞ ¼ wExc!MedPExcðtÞ  wInh!MedPInhðtÞ ð5Þ
where wExc!Med and wInh!Med are the weights of the excitatory and inhibitory projections
from Exc toMed and Inhib toMed, respectively. Inframedullary population SPN transmits the
activity ofMed but is additionally excited by the Meth-sensitive HD population as follows:
PSPNðtÞ ¼ PMedðtÞ þ wHD!SPNPHDðtÞ þ gSPN ð6Þ
Orexin and Temperature Response to Meth and Stress
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where wHD!SPN is the weight of the excitatory projection fromHD to SPN, and γSPN is the
basal excitability of SPN.
The temperature response is modeled by a first-order linear ODE driven by the SPN signal
as follows:
tT
dT
dt
¼ PSPNðtÞ  ðT  T0Þ ð7Þ
where T is the body temperature in degrees Celsius, τT is the time constant of the temperature
response, and T0 is the baseline body temperature.
Statistical Analysis. We used the Bayesian approach for inferring the model parameters.
Then, statistical analysis is used to estimate statistical significance of changes in (wS, wExc, wInh,
wHD) individually when 30, 10, and 0 mg/kg of SB are injected, respectively. To do this, we con-
structed a corresponding posterior probability density function (PDF) of the parameter vector
= (wS, wExc, wInh, wHD) considering other parameters fixed at values shown in the Table 1. Ac-
cording to Bayes' rule, this probability distribution is proportional to the probability that an ob-
served temperature time series {Ti} is produced by our model with the givenW, usually
referred to as a likelihood. Assuming that the residuals are normally distributed, the posterior
PDF p(W | {Ti}) is given by the following formula:
pðW jfTigÞ ¼ exp 
X180
i¼50
½Ti  TðW; iÞ2
2s2i
 
ð8Þ
where T(W, i) is the temperature calculated by our model at time i with the givenW. Ti and σi
are respectively a mean and a standard deviation of the body temperature over a corresponding
group of animals at time i by increments of 2 minutes.
We used the Markov Chain Monte Carlo (MCMC) approach, in particular the modified
Metropolis-Hastings algorithm [34–37], to create an ensemble of points distributed according
to the PDF (8). Once we had the ensembles, we calculated mean values of the parameters and
their standard errors for each group: vehicle, SB10, and SB30, and used two-sample z-test to es-
timate statistical significance of the differences in parameter values between the groups. We as-
sumed that p-value< 0.05 means that SB has a statistically-significant effect on the
corresponding parameter of the model.
Results
SB-334867 suppresses stress-induced hyperthermia
The first intraperitoneal injections evoked increases in the body temperature, which tended to
return to baseline before the second injection in some groups. We have pooled the responses to
the first injection in all groups before administration of Meth according to pretreatment to
Table 1. Values of parameters of the model, which were considered not affected by SB (adapted from
[30]).
Parameter Value Parameter Value
τu(Meth), min 8.25 τT, min 89.2
τd(Meth), min 57.5 T0, °C 37
τ(Stress), min 10 γExc, mg/kg −0.357
wExc!Mdl, °C 9.89 γInh, mg/kg −1.335
wInh!Mdl, °C 6.38 γHD, mg/kg −3.69
wHD!SPN, °C 5.66 γSPN, °C −3.35
doi:10.1371/journal.pone.0126719.t001
Orexin and Temperature Response to Meth and Stress
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make four groups (two doses of SB and two vehicles for each dose of SB). However, there was
no difference between responses to different vehicles, so data for both vehicles were pooled to-
gether as a single group. This reduced the number of groups to three. The increase of body tem-
perature in response to the first injection was statistically significantly attenuated by both doses
of SB (Fig 2), whereas there was no statistically significant difference between the two doses of
SB (p>0.05).
Effects of SB-334867 on temperature responses to Meth
The effects of Meth on body temperature were not different between the two vehicles used for
the different doses of SB. These effects had complex dose-dependence, which has previously
been described [29, 30, 38, 39]. In short, low (1 mg/kg) and high doses of Meth (10 mg/kg)
evoked virtually immediate response while response to intermediate dose (5 mg/kg) was de-
layed. Peak hyperthermia after low and intermediate doses was similar (38.2 ± 0.1°C vs 38.2±
0.1°C) but occurred at different moments (76±11 min vs 226±15 min after injection). The
highest dose of Meth evoked a robust hyperthermia with temperatures reaching 39.5±0.2°C
within 90 min of administration with the temperature subsequently declining from 90 to 150
min, followed by a plateau until the end of the recording period (up to 200 min). Injections of
saline evoked slight increases of body temperature, which were short-lived: temperature re-
turned to baseline within 60 min.
Fig 2. Effect of SB-334867 on stress-induced body temperature increase associated with i.p. injections (n = 24–26 per group). Black circles, solid
line—pooled vehicle data; open circles, solid line—SB 10 mg/kg; open circles, dashed line—SB 30 mg/kg. Injection was performed at t = –30 min.
doi:10.1371/journal.pone.0126719.g002
Orexin and Temperature Response to Meth and Stress
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The responses to the same doses of Meth after SB are shown in Fig 3. After the low dose of
Meth (1 mg/kg), rats treated with SB had lower body temperature than rats treated with vehicle
during 3 h after administration of Meth (Fig 3B and 3F). However, this difference did not at
any time reach statistical significance in the experiment with the lower dose of SB (10 mg/kg,
Fig 3B). However, the suppression of the response to the low dose of Meth became statistically
significant after the injection of higher dose of the antagonist (30 mg/kg, Fig 3F).
Next, after an intermediate dose of Meth (5 mg/kg) temperature transiently increased but
remained lower than temperatures in the vehicle group. Furthermore, this dose of SB signifi-
cantly attenuated thermogenic response after 70–90 min. In contrast, after the higher dose of
SB (30 mg/kg) intermediate dose of Meth evoked a rapid hyperthermic response (Fig 3G) such
that core temperature rose statistically significantly above the vehicle group. Qualitatively this
response resembles a temperature response to a high dose of Meth in the vehicle group (Fig
3D).
Finally, the response to a high dose of Meth (10 mg/kg) was not modified by the lower dose
of SB (Fig 3D) whereas the higher dose of SB significantly increased and prolonged the re-
sponse to the high dose of Meth with the difference progressively increasing for over 120 min
after the administration of Meth.
Effects of SB on estimates of the model parameters
In this study we used the Metropolis algorithm to implement a Markov Chain Monte Carlo ap-
proach to estimate the posterior distribution of model parameters. Specifically, this algorithm
generates a multidimensional cloud of points in the parameter space distributed according to
the PDF (formula 8 in Methods) for a given experimental series {Ti}. Four parameters (wS,
wExc, wInh, wHD) have been sampled for three different doses of SB. We demonstrate the corre-
sponding clouds in projections onto (wExc, wInh) and onto (wS, wHD)-planes shown in Fig 4A
and 4B respectively. Each panel contains three clouds labeled “Vehicle”, “SB, 10 mg/kg” and
“SB, 30 mg/kg”. These clouds are well separated implying that the differences in parameter val-
ues are statistically significant.
Statistical analysis confirms that antagonism of orexin receptors leads to statistically signifi-
cant changes in estimates of the model parameters. Particularly, the stress amplitude wS is re-
duced by administration of the orexin antagonist (Fig 4C), although, there was no significant
difference in wS estimates between 10 and 30 mg/kg of the antagonist. Also, parameters of sen-
sitivity to Meth of both excitatory and inhibitory drives, wExc, wInh, were decreased by adminis-
tration of SB (Fig 4D and 4E). The suppression was dose-dependent. The lower dose of the
antagonist significantly decreased wExc, but the effect was virtually absent for wInh. However,
the higher dose of SB was much more efficient in suppressing the Meth sensitivity of both the
inhibitory and excitatory drives. Finally, the Meth sensitivity of HD node was progressively in-
creased with increasing dose of SB (Fig 4F) implying an ability of this population to be activat-
ed by progressively lower doses of Meth.
Effects of SB on the network components
Of particular interest is how SB-evoked changes in the parameters of the model affect activa-
tion profiles of Meth-sensitive network components. Activities of Exc, Inhib andHD as func-
tions of the blood concentration of Meth are shown at Fig 5A, 5B and 5C. SB downgrades the
slope of the dose-dependence curve in case of Exc and Inhib, which signifies desensitization of
these nodes (more Meth is required to evoke same response). The effect of SB on Exc is signifi-
cant for both doses of antagonist and increases with dose. In contrast, an effect of the lower
dose of SB on Inhib is subtle. Unlike two other Meth sensitive populations, HD gains higher
Orexin and Temperature Response to Meth and Stress
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Fig 3. Changes in the body temperature evoked by methamphetamine after two doses of SB-334867.Meth is injected at t = 0 min (dashed lines). SB is
injected 30 min prior to Meth.A-D: SB 10 mg/kg; E-H: SB 30 mg/kg. Each plot contains responses to the dose of Meth shown on the left: 0 (Saline), 1, 5 or 10
mg/kg after injection of either vehicle (black circles) or SB (open circles).
doi:10.1371/journal.pone.0126719.g003
Orexin and Temperature Response to Meth and Stress
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sensitivity to Meth when SB is present as its dose-dependence curve shifts to the left. Therefore,
lower concentrations of Meth are able to activate this neuronal population.
Superposition of inputs from these populations results in complex modification of SPN ac-
tivity which ultimately controls the thermal response. The dose-dependence of SPN activity is
shown in the Fig 5D, which is aligned with simulated pharmacokinetic profile of Meth after
various doses of Meth used in this study (Fig 5E). The low dose of Meth (1 mg/kg, Meth-1 in.
5E) does not evoke any significant response when either of SB doses is present.
Fig 4. Parameter estimates generated by Monte-Carlo simulations. A-B: Statistical ensembles of parameters (amplitude of stress, and Meth-sensitivities
of three Meth-dependent populations) projected onto (wS,wHD)-plane (A) and (wExc,wInh)-plane (B) for each of the three doses of SB (vehicle, 10 and 30 mg/
kg). C-F: Individual parameters for each dose of SB. * denotes statistically significant difference from vehicle (SB 0, p<0.05); #—between SB 10 and SB 30
(p<0.05).
doi:10.1371/journal.pone.0126719.g004
Orexin and Temperature Response to Meth and Stress
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The intermediate Meth dose (5 mg/kg, Meth-5 in Fig 5E) is sufficient to elicit strong ther-
mogenesis after the higher dose of SB (30 mg/kg, SB30 in Fig 5D) but not after the lower dose
of the antagonist (10 mg/kg, SB10 in Fig 5D). 10 mg/kg of SB desensitizes Exc, barely affects
Inhib, and sensitizes HD. Together these changes leave the activity of SPN at the peak Meth
concentration caused by the injection of 5 mg/kg of Meth almost unaltered (Fig 5D and 5E). In
contrast, 30 mg/kg of SB sensitize HD a little more (Fig 5C), but more importantly this dose
substantially desensitizes the Inhib population (Fig 5B) leading to disinhibition of SPN activity
(compare SB10 and SB30 in Fig 5D).
As mentioned SB induces sensitization ofHD population to Meth (Figs 4F and 5C) which
results in longer activation of theHD component by the same Meth concentration profile
Fig 5. Activation curves of nodes of the model compared with pharmacokinetics of Meth. A-D: Activity of the network nodes as functions of Meth
concentration in the blood after three doses of SB-334867: 0 (Veh), 10 and 30 mg/kg using best fit parameters. E: Time courses of the Meth concentration
after different doses of Meth (1, 5 and 10 mg/kg) as generated by the model.
doi:10.1371/journal.pone.0126719.g005
Orexin and Temperature Response to Meth and Stress
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(Meth-10 in Fig 5E) due to progressively lowerHD activation threshold (compare Veh, SB10
and SB30 in Fig 5D).
Effects of SB on the temperature responses to Meth explained
Control responses to Meth. Without SB and Meth, injections of the vehicle and saline
cause stress which activates Exc (see Fig 1). This activation results in two early “peaks” of tem-
perature in the beginning due to two injections separated by 30 min, followed by a decline to
baseline (Fig 6A).
For 1 mg/kg of Meth, stress and Meth together activate Exc far greater than Inhib resulting
in higher and longer maximum temperature after 1 mg/kg than after saline, however, the grad-
ual decline afterwards was similar (Fig 6B).
Following the vehicle, the intermediate dose of Meth (5 mg/kg) activates both Exc and Inhib
to their full extent effectively cancelling each other, and the second “stress bump” almost
completely disappears. Accordingly, the body temperature does not react until after 60 min
when the Meth concentration falls below the activation threshold of Inhib. This explains the
plateau and gradual increase in temperature in the late phase (Fig 6C).
Finally, after 10 mg/kg of Meth at the early stage the activation levels of Exc and Inhib are
saturated and negating each other.HD component is activated which results in an immediate
robust temperature increase (Fig 6D). After approximately 70 min the Meth concentration falls
belowHD’s activation threshold, and the temperature starts declining. Later on, in about 120
min, Meth decreases enough to deactivate Inhib and, thus, to disinhibit Exc which temporarily
slows the temperature drop or even initiates a secondary peak (not seen in Fig 6D).
For more details about temperature responses to Meth alone see [30].
Responses to Meth after SB. Administration of SB itself results in a spike in temperature
due to stress caused by the injection which is partially suppressed by the drug (see Fig 2). The
second bump on the temperature curve in Fig 6E corresponds to the injection of saline. The
suppression of the responses to stress does not increase significantly with increasing dose of
the orexin antagonist (compare Fig 6E and 6I).
After administration of SB the temperature response to the low dose of Meth does not ex-
ceed that of animals injected with saline (compare Fig 6F and 6J with Fig 6E and 6I) suggesting
that the temperature responses to the low dose of Meth are eliminated (see Fig 5D).
At the intermediate dose of Meth (5 mg/kg) the temperature responses are noticeably and
differentially altered by 10 and 30 mg/kg of SB (Fig 6C, 6G and 6K). After 10 mg/kg of SB the
temperature curve loses the late ascending phase present in Fig 5C. This modification is con-
cerned with SB-evoked desensitization of Exc to Meth (see Figs 4D, 5A and 5D). After the
higher dose of SB (30 mg/kg) there appears strong immediate hyperthermia (Fig 6K) explained
by sensitization ofHD and desensitization of Inhib (Fig 5B, 5C and 5D).
Finally, after 10 mg/kg of Meth, both Exc and Inhib are activated to some extent by over-
coming the blockade, but activation ofHD overshadows the activity of the two, producing pro-
gressively larger temperature increase with increasing dose of SB (Fig 6D, 6H and 6L). This
augmented hyperthermia as well as its longer duration are also mediated by SB-induced sensiti-
zation of the HD node and desensitization of Inhib to Meth (see Fig 5).
Mechanism of HD sensitization. Orexin is an excitatory neurotransmitter [40]. Accord-
ingly, a blockade of orexin receptors is expected to reduce the activity of the postsynaptic neu-
rons in presence of orexinergic synaptic inputs. From this perspective, the desensitization of
Exc and Inhib populations by the orexin antagonist allows for a straightforward interpretation.
Specifically, we can assume that these two nodes receive orexinergic projections fromMeth-
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activated neurons, and, hence, these inputs are suppressed by the orexin receptor antagonism
(see Fig 2).
In the model presented in Fig 1 we assumed that SB affects the parameters of sensitivity of
Meth-dependent populations wExc, wInh. This worked out very well to reproduce the data and
is consistent with orexin excitatory action. In contrast, the HD population gets sensitized by
the antagonist, which contradicts to the excitatory influence of orexin. Therefore, we assume
that Meth-activated excitatory input, which this node receives, is not mediated by orexin. In-
stead, HD node may receive strong inhibition from another neural population whose activity is
controlled by orexin receptors. In the presence of the orexin antagonist the activity of this in-
hibitory population gets reduced which in turn disinhibits HD (Fig 7A).Therefore, progressive
sensitization ofHD (Fig 4F), which was described above by an increase in wHD, is more likely a
result of HD disinhibition as illustrated in Fig 7A.
The orexinergic drive in Fig 7A can be Meth-dependent or Meth-independent. In the for-
mer case the net Meth-dependent input to HD will be defined by the difference of Meth-in-
duced excitation and inhibition. In presence of SB, the inhibition is reduced which results in
the increased HD sensitivity to Meth characterized by the parameter wHD. In the latter case, the
Fig 6. Comparison of experimental data andmodel responses. Experimental data shown by open circles (average temperature); error bars represent
standard deviations over a group of rats. Model responses using best fit parameters are shown as a thick lines. SB vehicles for both doses were pooled into a
single group. Columns of graphs correspond to different doses of the antagonist (A-D: Vehicle, E-H: 10 mg/kg and I-K: 30 mg/kg as marked at the top), rows
of graphs correspond to different doses of Meth (Saline, 1, 5 and 10 mg/kg, as marked at the left).
doi:10.1371/journal.pone.0126719.g006
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orexin antagonist does not affect the Meth-dependent input directly. It rather alters the basal
excitability of the HD population defined by the orexin-dependent tonic inhibition it receives.
Accordingly, a more biologically correct way to describe this is to alter γHD for different doses
of SB, rather than wHD.
γHD estimates obtained by Monte Carlo simulations using (wS, wExc, wInh, γHD) as a set of
SB-affected parameters are shown in Fig 7B. As expected, this parameter progressively declines
with increasing SB dose which leads to changes inHD activation curve almost indistinguish-
able from shown in Fig 5C. Obviously, the likelihood for these two models is almost the same,
and hence they are equally probable from Bayesian standpoint.
To summarize, the sensitization of HD component of the network is concerned with its dis-
inhibition. Our experimental data does not allow for a conclusion if this inhibition is Meth-ac-
tivated or not.
Effect of inhibition failure
The inhibitory control of HD population described above may originate from the Inhib node of
the circuitry (see Fig 1). In this case we can synthesize the network architecture by combining
the schematics from Figs 1A and 7A as shown in Fig 8A. We implemented a corresponding
Fig 7. Interpretation of HD sensitization as a change of inhibitory tone to the HD. A: The mechanism of
HD sensitization by the orexin receptor antagonist. SB suppresses activation of the inhibitory population
InhHD by orexinergic input which disinhibits HD and thus lowers its activation threshold. B: Effect of SB on the
basal inhibitory tone to HD population γHDwhen it is used as an SB-affected parameter instead ofwHD. *—
the estimate is statistically significantly different from the one for Vehicle (SB-0, p<0.05); #—the estimates are
statistically significantly different between SB 10 and SB 30 (p<0.05). See Results for more details.
doi:10.1371/journal.pone.0126719.g007
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Fig 8. Reducedmodel and effect of inhibitory failure on the response. A. The extended model schematic in which the inhibitory tone to HD originates
from Inhib population (see explanations in the Results). B: Effect of inhibitory failure in the modified model on the response to 3 mg/kg of Meth (see details in
the Results).
doi:10.1371/journal.pone.0126719.g008
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mathematical model and found that it fitted our experimental data with comparable precision
(not shown) and hence had similar likelihood.
This model has a very important implication for the role of inhibition in this system. Indeed,
both excitatory components, Exc and HD, appear to be controlled by the inhibitory drive
whose failure may have dramatic consequences. Our simulations demonstrate the conse-
quences of such failure. Fig 8B demonstrates how temperature responses to Meth change if the
maximal activity of Inhib population is bounded. In our simulations we used a relatively low
dose (3 mg/kg) which does not produce major response under baseline conditions (see unmod-
ified 100% inhibition in Fig 8B). If the maximal activity of the Inhib population was decreased
by two times (50% inhibition), the body temperature rose by almost 2 degrees. When Inhib was
completely silenced, the body temperature reached life-threatening levels at almost 40°C (0%
inhibition in Fig 8B).
Discussion
This study builds upon previously published mathematical models [30], which were based on
the premise that body temperature response to Meth is dependent upon the interaction be-
tween two neural components: excitatory and inhibitory drives. The difference in strength be-
tween these two signals ultimately determines the dynamics of body temperature.
The injections of SB (0 mg/kg, 10 mg/kg, and 30 mg/kg) differentially modify temperature
responses to low, intermediate and high doses of Meth (0 mg/kg, 1 mg/kg, 5 mg/kg, and 10
mg/kg). Previously it was reported that 10 mg/kg of SB suppressed the temperature response to
stress of injection and also late hyperthermia induced by the intermediate (5 mg/kg) dose of
Meth [29]. The limited conclusiveness of that study was concerned with the fact that SB-related
effects on the temperature response in the early phase (t< 60 min) were impossible to separate
from stress-induced temperature fluctuations resulting from two intraperitoneal injections.
In this study using mathematical modeling we were able to reliably decompose the effect of
SB into stress- and Meth-related components, and thus provide a straight-forward mechanistic
explanation for the intricate alterations of the temperature responses to different doses of Meth
induced by orexin receptor antagonism.
Two excitatory components in temperature responses to Meth
In our previous publication [30], where we suggested the circuitry shown in Fig 1 to explain
the complexity of the temperature responses to Meth, we also considered an alternative model
where the excitatory populations, Exc and HD, were combined into a single excitatory node.
The data used in that study failed to emphasize the plausibility of either architecture.
In the present study we have shown that two distinct excitatory populations are necessary to
explain differential effects of the orexin receptor antagonist on the responses to low and high
doses of Meth. Specifically, activation of the first excitatory population (Exc in Fig 8A) by low
doses of Meth is mediated by orexinergic neurotransmission, while the direct Meth-dependent
input to the second population (HD) does not rely on orexin receptor activation.
The details of the network architecture shown in Figs 7A and 8A clarify the nature of high
activation threshold of the HD component which is yet another distinctive feature of the sec-
ond excitatory population in the network. The lack of response of this population to low doses
of Meth is not concerned with its lower sensitivity, but rather defined by a tight inhibitory con-
trol originated either from Inhib or some other inhibitory neuronal population(s). High doses
of Meth are needed to overcome this inhibition. In either case the source of this inhibition is
dependent upon orexinergic input. Orexin receptor antagonism suppresses the inhibition and
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thus lowers HD activation threshold which underlies SB-induced exaggeration of responses to
high doses of Meth.
Biological implications
The results of this work have several important implications to consider.
Amphetamines are known to activate orexin-containing neurons in the perifornical area
and dorsomedial hypothalamus [20, 21]. From the phenomena observed in our experiments
we conclude that this activation of orexinergic cells is required for temperature responses to
Meth. Due to absence of hypothermia after administration of SB, we conclude that existing
orexinergic projection to raphe pallidus [41] does not mediate temperature responses to Meth
based on assumed locations of Excitatory and Medullary nodes [30]. In turn, the entire hypo-
thalamus including dorsomedial hypothalamus contains orexin-containing fibers [41], which
can mediate the above effects of Meth. However, this transmission can be not mono-, but poly-
synaptic (for example, perifornical area—ventral tegmental area—hypothalamus, or have even
more connections).
The Inhib population in the network plays an extremely important role in counteracting hy-
perthermia. Previously, we have demonstrated that an imbalance of excitatory and inhibitory
components can result in significant amplification of the response to relatively low doses of
Meth [30]. The details of the circuitry proposed in this study emphasize the importance of the
inhibitory component(s) even more. Simulations shown in Fig 8B demonstrate that a relatively
low dose (3 mg/kg), which does not induce virtually any response in intact animals (see 100%
inhibition in Fig 8B), can evoke profound hyperthermia typical for much higher doses (com-
pare 0% inhibition in Fig 8B with Fig 6D). The impairment of the inhibitory control can not
only allow excitation to pass throughMed, but also lower theHD activation threshold so that
this population gets activated by relatively low Meth doses.
Another implication of our results is that using orexin receptor blockade as a treatment for
other ailments could cause life-threatening side effects. In particular, orexin antagonists were
proposed to prevent or treat addictions to various drugs [42, 43]. An increase in excitability of
theHD population in presence of SB highlights a potential danger of its use to treat drug abuse
if the person uses the drug during treatment. Indeed, suppression of acute effects of amphet-
amines by the orexin antagonist may force an abuser to increase the dose which may cause life-
threatening hyperthermia due to a dysfunction of the inhibitory population(s). Similarly, our
model predicts that narcoleptic patients, whose condition is putatively caused by a lack of
orexin [44], may be at higher risk of life-threatening overdose of amphetamine-like stimulants,
which are usually prescribed to treat such patients [45].
Tupone, Madden (26) reported that administration of orexin into raphe pallidus evoked ac-
tivation of thermogenesis in the BAT and increased body temperature in anesthetized rats. Sur-
prisingly, local microinjection of SB into the same area also induced thermogenesis and
hyperthermia [26]. Our analysis provides possible interpretation of this data as the network
has both excitatory and inhibitory populations activated by orexin. Namely, activation of the
excitatory drive by orexin can evoke thermogenic response, whereas a blockade of orexin re-
ceptors in the inhibitory population will remove the inhibitory tone which may result in a
similar effect.
Conclusions
In this study, using mathematical modeling, we mechanistically explained non-trivial alter-
ations of temperature response to various doses of Meth at presence of the orexin receptor an-
tagonist. Our model can be used to generate experimentally-testable predictions on the
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thermogenic effects of Meth when activity of orexin receptors is modified. The model has sev-
eral essential features regarding the mechanisms of Meth-evoked hyperthermia and stress
response.
• Both low dose of Meth and stress activate the excitatory component which is mediated by
orexin receptors and hence can be suppressed by SB.
• The inhibitory component of the response to Meth is also mediated by orexin.
• Orexin antagonism disinhibits, and thus increases the sensitivity of the component normally
activated by the high dose of Meth.
• Insufficient inhibitory drive can cause fatal hyperthermia after relatively low doses of Meth.
This insufficiency can be provoked by a decreased orexinergic tone either due to deficiency
of orexinergic transmission (narcolepsy) or after administration of orexin receptor antago-
nists (e.g. used for drug abuse treatments).
Supporting Information
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